Vorinostat Recruiting Phase 2 Trials for Neuroblastomas Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02035137131I-MIBG Alone VS. 131I-MIBG With Vincristine and Irinotecan VS131I-MIBG With Vorinistat
NCT02559778Pediatric Precision Laboratory Advanced Neuroblastoma Therapy